Literature DB >> 16186357

Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model.

Kyle I Swanson1, Christopher R Schlieve, Christopher J Lieven, Leonard A Levin.   

Abstract

PURPOSE: The signaling of retinal ganglion cell (RGC) death after axotomy is partly dependent on the generation of reactive oxygen species. Shifting the RGC redox state toward reduction is protective in a dissociated mixed retinal culture model of axotomy. The hypothesis for the current study was that tris(2-carboxyethyl)phosphine (TCEP), a sulfhydryl reductant, would protect RGCs in a rat optic nerve crush model of axotomy.
METHODS: RGCs of postnatal day 4 to 5 Long-Evans rats were retrogradely labeled with the fluorescent tracer DiI. At approximately 8 weeks of age, the left optic nerve of each rat was crushed with forceps and, immediately after, 4 muL of TCEP (or vehicle alone) was injected into the vitreous at the pars plana to a final concentration of 6 or 60 microM. The right eye served as the control. Eight or 14 days after the crush, the animals were killed, retinal wholemounts prepared, and DiI-labeled RGCs counted. Bandeiraea simplicifolia lectin (BSL-1) was used to identify microglia.
RESULTS: The mean number of surviving RGCs at 8 days in eyes treated with 60 microM TCEP was significantly greater than in the vehicle group (1250 +/- 156 vs. 669 +/- 109 cells/mm(2); P = 0.0082). Similar results were recorded at 14 days. Labeling was not a result of microglia phagocytosing dying RGCs. No toxic effect on RGC survival was observed with TCEP injection alone.
CONCLUSIONS: The sulfhydryl-reducing agent TCEP is neuroprotective of RGCs in an optic nerve crush model. Sulfhydryl oxidative modification may be a final common pathway for the signaling of RGC death by reactive oxygen species after axotomy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186357     DOI: 10.1167/iovs.05-0155

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  Effectiveness of Novel Borane-Phosphine Complexes In Inhibiting Cell Death Depends on the Source of Superoxide Production Induced by Blockade of Mitochondrial Electron Transport.

Authors:  Emily A Seidler; Christopher J Lieven; Alex F Thompson; Leonard A Levin
Journal:  ACS Chem Neurosci       Date:  2010-02-17       Impact factor: 4.418

Review 2.  Iron homeostasis and eye disease.

Authors:  Allison Loh; Majda Hadziahmetovic; Joshua L Dunaief
Journal:  Biochim Biophys Acta       Date:  2008-11-14

3.  Redox proteomic identification of visual arrestin dimerization in photoreceptor degeneration after photic injury.

Authors:  Christopher J Lieven; Jonathan D Ribich; Megan E Crowe; Leonard A Levin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-26       Impact factor: 4.799

4.  Superoxide signaling and cell death in retinal ganglion cell axotomy: effects of metallocorroles.

Authors:  Maria-Magdalena Catrinescu; Wesley Chan; Atif Mahammed; Zeev Gross; Leonard A Levin
Journal:  Exp Eye Res       Date:  2012-02-16       Impact factor: 3.467

Review 5.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

6.  A cell-permeable phosphine-borane complex delays retinal ganglion cell death after axonal injury through activation of the pro-survival extracellular signal-regulated kinases 1/2 pathway.

Authors:  Mohammadali Almasieh; Christopher J Lieven; Leonard A Levin; Adriana Di Polo
Journal:  J Neurochem       Date:  2011-08-12       Impact factor: 5.372

7.  Polyester-based microdisc systems for sustained release of neuroprotective phosphine-borane complexes.

Authors:  David A Janus; Christopher J Lieven; Megan E Crowe; Leonard A Levin
Journal:  Pharm Dev Technol       Date:  2017-06-09       Impact factor: 3.133

8.  RetFM-J, an ImageJ-based module for automated counting and quantifying features of nuclei in retinal whole-mounts.

Authors:  Adam Hedberg-Buenz; Mark A Christopher; Carly J Lewis; Kacie J Meyer; Danielle S Rudd; Laura M Dutca; Kai Wang; Mona K Garvin; Todd E Scheetz; Michael D Abràmoff; Matthew M Harper; Michael G Anderson
Journal:  Exp Eye Res       Date:  2015-08-14       Impact factor: 3.467

Review 9.  Gene therapy targeting glaucoma: where are we?

Authors:  Xuyang Liu; Carol A Rasmussen; B'ann T Gabelt; Curtis R Brandt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

10.  Mechanisms of retinal ganglion specific-cell death in Leber hereditary optic neuropathy.

Authors:  Leonard A Levin
Journal:  Trans Am Ophthalmol Soc       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.